Top Markets
Coin of the day
Jiangsu Recbio Technology Co., Ltd. Jiangsu Recbio Technology Co., Ltd.

Jiangsu Recbio Technology Co., Ltd.

2179
Rang in Aktien #15657
Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company... Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.
Aktienkurs
$0.63963115
Zuletzt synchronisiert: 2026-08-26
Marktkapitalisierung
$339.16M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-35.23%
Land
CN
Handel Jiangsu Recbio Technology Co., Ltd. (2179)

Kategorie

Kursverlauf für Jiangsu Recbio Technology Co., Ltd. (2179)
Höchster Schlusskurs: $0.64 am 2026-08-01

Niedrigster Schlusskurs: $3.22 am 2022-03-01
Kursverlauf der Aktie von Jiangsu Recbio Technology Co., Ltd. von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 4.07%
2025 -37.60%
2024 -16.16%
2023 -55.93%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$550.06 40.67%
US
$1.03K 44.03%
NL
$150.50 524.74%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH